Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care
- 1 September 2002
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 3 (9) , 557-564
- https://doi.org/10.1016/s1470-2045(02)00853-7
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- American Society of Clinical Oncology Clinical Practice Guidelinesfor the Use of Chemotherapy and Radiotherapy ProtectantsJournal of Clinical Oncology, 1999
- The basis for current treatment recommendations for malignant gliomasJournal of Neuro-Oncology, 1994
- Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma TrialsJNCI Journal of the National Cancer Institute, 1993
- Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive radiation therapy oncology group (RTOG) clinical trialsInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Prognostic factors for high-grade malignant glioma: Development of a prognostic indexJournal of Neuro-Oncology, 1990
- Univariate and multivariate statistical analysis of high-grade gliomas: The relationship of radiation dose and other prognostic factorsInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implicationsCancer, 1985
- Survival and prognosis of patients with astrocytoma with atypical or anaplastic featuresJournal of Neuro-Oncology, 1985
- Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint radiation therapy oncology group and eastern cooperative oncology group studyCancer, 1983